{
  "meta": {
    "title": "Ca_Endometrium_Cervix_Vulva_Vagina_Miscellaneous",
    "url": "https://brainandscalpel.vercel.app/ca-endometrium-cervix-vulva-vagina-miscellaneous-5c167ddd.html",
    "scrapedAt": "2025-11-30T11:13:55.613Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity </span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Family history</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Use of hormone replacement therapy</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Early menopause</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are recognized risk factors for the development of endometrial carcinoma, except:</span></p>",
      "unique_key": "DT1190153",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190153,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Early menopause is generally considered a protective factor or, at least, not a risk factor for endometrial carcinoma.</strong></li>\n<li>Endometrial carcinoma is primarily linked to prolonged, <strong>unopposed estrogen exposure</strong>.</li>\n<li>Early menopause means a shorter duration of a woman's reproductive life and thus less lifetime estrogen exposure, which tends to <strong>decrease the risk</strong>.</li>\n<li>In contrast, <strong>late menopause</strong> is a known risk factor because it extends the period of estrogen exposure.</li>\n</ul>\n<p><strong>Protective factors:</strong></p>\n<ul>\n<li>Oral contraceptive pills (combined addition of Progesterone to HRT).</li>\n</ul>\n<p><strong>Predisposing factors are:</strong></p>\n<p><strong>Mnemonic:</strong> Family has OLD AUNTY</p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404014ef93f0e-7a25-44b9-9999-568d3ad6ff77.jpg\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Obesity (Option A):</strong> Obese individuals have higher levels of endogenous estrogens due to increased peripheral conversion of androgens to estrogens in adipose tissue, leading to prolonged unopposed estrogen exposure.</p>\n<p><strong>Family history (Option B):</strong> Approximately 5% of endometrial cancers are hereditary, primarily associated with <strong>Lynch syndrome II (HNPCC)</strong>, which significantly increases the risk of endometrial cancer as well as other malignancies.</p>\n<p><strong>Use of hormone replacement therapy (Option C):</strong> Unopposed estrogen in HRT promotes endometrial proliferation, increasing cancer risk. The addition of progesterone to HRT is protective against this effect.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Endometrial carcinoma development is strongly linked to <strong>unopposed estrogen exposure</strong>.</li>\n<li><strong>Obesity, family history (especially Lynch syndrome), and estrogen-only HRT</strong> are significant risk factors.</li>\n<li><strong>Early menopause</strong> is generally considered <strong>protective</strong>, while <strong>late menopause</strong> is a risk factor.</li>\n<li><strong>Combined oral contraceptive pills and smoking</strong> are considered <strong>protective factors</strong>.</li>\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrium Ca </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovary Ca</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervix Ca</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Vagina Ca</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old woman with a history of ER-positive breast cancer presents for a routine follow-up. She completed chemotherapy 2 years ago and is currently on oral hormonal therapy. She now complains of occasional spotting per vaginum over the past month. Pelvic examination is unremarkable.<br>Which of the following malignancies is she most at risk of developing as a side effect of her ongoing treatment?</span></p>",
      "unique_key": "DT1190159",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The patient's history of ER-positive breast cancer and current oral hormonal therapy, specifically long-term tamoxifen therapy (a common hormonal treatment for ER-positive breast cancer), places her at a significantly increased risk for <strong>Endometrial Carcinoma (Endometrium Ca)</strong>.</li>\r\n<li>Tamoxifen is known to exert a estrogenic effect on the endometrium, which can predispose to endometrial hyperplasia and, subsequently, endometrial cancer.</li>\r\n<li><strong>Malignancies caused by long-term tamoxifen therapy:</strong>\r\n<ul>\r\n<li>Carcinoma endometrium-it is the most common carcinoma associated with it.</li>\r\n<li>Uterine sarcoma.</li>\r\n<li>Rarely liver cancer with long-term high dose.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Non malignant effects of tamoxifen on uterus:</strong>\r\n<ul>\r\n<li>Endometrial hyperplasia</li>\r\n<li>Endometriosis</li>\r\n<li>Fibroid uterus</li>\r\n<li>Ovarian cysts</li>\r\n<li>Menstrual irregularities or amenorrhea.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Ovary Ca (Option B):</strong> While tamoxifen can cause ovarian cysts, it is not primarily associated with an increased risk of ovarian cancer. The direct link with malignancy is much stronger for the endometrium.</p>\r\n<p><strong>Cervix Ca (Option C):</strong> Tamoxifen therapy is not a known predisposing factor for cervical cancer. Cervical cancer is primarily associated with Human Papillomavirus (HPV) infection.</p>\r\n<p><strong>Vagina Ca (Option D):</strong> Tamoxifen is not typically associated with an increased risk of vaginal cancer.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Long-term tamoxifen therapy, used in the treatment of ER-positive breast cancer, is a well-established risk factor for <strong>endometrial hyperplasia and, most commonly, endometrial carcinoma</strong>.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma in situ of cervix</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma endometrium</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysfunctional uterine bleeding (DUB) </span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman, nulliparous, diabetic, and obese presents with postmenopausal bleeding. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1190162",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190162,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient's presentation with postmenopausal bleeding, coupled with multiple significant risk factors including <strong>nulliparity, diabetes mellitus (DM), and obesity</strong>, strongly points to <strong>Carcinoma endometrium</strong> as the most likely diagnosis.</p>\r\n<p>These factors are classic components of the <strong>Corpus Cancer Syndrome</strong>. This syndrome specifically refers to a cluster of conditions (obesity, diabetes, and hypertension, often with nulliparity or infertility) that increase the risk of endometrial cancer, primarily by leading to <strong>prolonged exposure to unopposed estrogen</strong>.</p>\r\n<p>Unopposed estrogen stimulates excessive endometrial proliferation, significantly increasing the risk of endometrial hyperplasia and subsequent Type I endometrioid carcinoma. Postmenopausal bleeding, in particular, is a cardinal symptom of endometrial cancer and always warrants immediate investigation in a high-risk individual.</p>\r\n<h3><strong>Explanation of other options:</strong></h3>\r\n<p><strong>Carcinoma in situ of cervix (Option A):</strong> Carcinoma in situ of the cervix is typically associated with Human Papillomavirus (HPV) infection and often presents with abnormal Pap test results or post-coital bleeding. While it is a gynecological malignancy, the patient's specific constellation of risk factors (nulliparity, obesity, diabetes) is not directly linked to cervical cancer, but rather to endometrial cancer.</p>\r\n<p><strong>Dysfunctional uterine bleeding (DUB) (Option C):</strong> Dysfunctional uterine bleeding (now often referred to as AUB: abnormal uterine bleeding) typically refers to abnormal bleeding in premenopausal women due to hormonal imbalances, without underlying structural pathology or malignancy. In a postmenopausal woman, any bleeding is considered abnormal and must be thoroughly investigated to rule out malignancy, especially with multiple risk factors present. Attributing postmenopausal bleeding to \"DUB\" without ruling out cancer would be a significant oversight.</p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509020e546553-409b-45b5-9bf7-8e951e119da1.png\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509029dc932f6-491b-4e42-aba3-ee2065647d62.png\">\r\n<h3><strong>Key Takeaway:</strong></h3><p>Postmenopausal bleeding, especially in a nulliparous, diabetic, and obese woman, is a critical symptom strongly suggestive of <strong>endometrial carcinoma</strong> due to the cumulative effect of prolonged unopposed estrogen exposure. This clinical scenario demands immediate and thorough evaluation to confirm or rule out malignancy.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma </span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoacanthoma</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed adenosquamous carcinoma</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Clear cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most malignant endometrial carcinoma is:</span></p>",
      "unique_key": "DT1190173",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190173,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Clear cell carcinoma</strong> is the most malignant type of endometrial carcinoma.</li>\r\n<li>Clear cell carcinoma falls under the Type II (Nonendometrioid) category.</li>\r\n<li>Type II endometrial cancers are characterized by being <strong>postmenopausal, aggressive behavior, high grade, and often with deep myometrial invasion</strong>.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240401086ac969-bfa2-4a6d-9543-f3b6e6da076d.jpg\">\r\n<p><strong>Clear Cell Carcinoma</strong></p>\r\n<ul>\r\n<li>Accounts for <strong>&lt;5%</strong> of all endometrial carcinomas.</li>\r\n<li>Histological hallmark: <strong>hobnail cells</strong>.</li>\r\n<li>Occurs mostly in <strong>older women</strong>.</li>\r\n<li>Highly <strong>aggressive</strong> tumor subtype.</li>\r\n<li>Prognosis: <strong>similar to or worse than papillary serous carcinoma</strong>.</li>\r\n</ul>\r\n<h3><strong>Explanation of Other Options:</strong></h3>\r\n<p><strong>Adenocarcinoma (Option A):</strong> This is a broad term for a type of cancer that forms in glandular tissue. Endometrioid adenocarcinoma is the most common type (Type I) and is generally less aggressive (low grade, stable behavior) than Type II cancers like clear cell carcinoma.</p>\r\n<p><strong>Adenoacanthoma (Option B):</strong> This term is often used to describe endometrioid adenocarcinoma with benign squamous differentiation. It falls under the endometrioid (Type I) category, which generally has a better prognosis and is less aggressive than Type II cancers.</p>\r\n<p><strong>Mixed adenosquamous carcinoma (Option C):</strong> This type contains both adenocarcinoma and malignant squamous components. While it can be more aggressive than pure endometrioid adenocarcinoma, it is generally considered less aggressive than clear cell or serous carcinomas, which are explicitly stated as highly aggressive Type II cancers. The information provided specifically highlights clear cell carcinoma's aggression.</p>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>Among the options, <strong>Clear cell carcinoma</strong> is explicitly identified as a <strong>Type II (Nonendometrioid) endometrial cancer</strong>, characterized by its <strong>aggressive behavior, high grade, and poor prognosis</strong>, making it the most malignant type.</p>\r\n",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">I</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">II</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">III</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma endometrium with Para-aortic lymph node status is classified as stage:</span></p>",
      "unique_key": "DT1190182",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>According to the FIGO (International Federation of Gynecology and Obstetrics) staging guidelines for endometrial carcinoma, involvement of the para-aortic lymph nodes classifies the cancer as Stage III.</strong></li>\r\n<li>Stage III includes local and/or regional spread, specifically encompassing involvement of pelvic or para-aortic lymph nodes, serosa, adnexa, and/or vaginal or parametrial involvement.</li>\r\n<li>Therefore, the presence of carcinoma cells in the para-aortic lymph nodes indicates spread beyond the immediate uterine region but still within regional lymphatic drainage, classifying it as Stage III.</li>\r\n<li><strong>Stage IIIA - \"South African\"</strong>\r\n<ul>\r\n<li><strong>S</strong>outh &rarr; <strong>S</strong>erosa (lower 1/3 of vagina involved)</li>\r\n<li><strong>A</strong>frican &rarr; <strong>A</strong>dnexa (parametrial extension but not to pelvic wall)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Stage IIIB - \"Vice President\"</strong>\r\n<ul>\r\n<li><strong>V</strong>ice &rarr; <strong>V</strong>agina (entire pelvic wall or lower 1/3 of vagina)</li>\r\n<li><strong>P</strong>resident &rarr; <strong>P</strong>arametrium (extension to pelvic wall or hydronephrosis)</li>\r\n</ul>\r\n</li>\r\n<li><strong>Stage IIIC - Lymph Nodes</strong></li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<ul>\r\n<li><strong>I :</strong> Stage I indicates the cancer is <strong>confined to the uterus</strong>. Para-aortic lymph node involvement means the cancer has spread beyond the uterus, so it cannot be Stage I.</li>\r\n<li><strong>II (Option B):</strong> Stage II indicates <strong>invasion of the cervical stroma</strong>. While this is more advanced than Stage I, it does not include distant lymph node involvement like the para-aortic nodes.</li>\r\n<li><strong>IV (Option D):</strong> Stage IV indicates <strong>distant metastasis</strong> (e.g., to the bladder or bowel mucosa, or distant organs). While para-aortic involvement is advanced, it is still considered regional lymphatic spread rather than distant metastasis in the context of endometrial cancer staging unless other distant sites are involved.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>In endometrial carcinoma, the presence of malignant cells in <strong>Para-aortic lymph nodes</strong> signifies regional lymphatic spread. This specific involvement is classified as <strong>Stage III</strong> disease according to FIGO staging.</li>\r\n<li>Understanding FIGO staging is critical for treatment planning and prognosis.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240704601aa228-ad99-4605-87b9-1cfd96e668ad.jpg\">",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Para-aortic </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">External iliac</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior mesenteric</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Inguinal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following lymph nodes is not typically involved in the regional lymphatic drainage of endometrial carcinoma?</span></p>",
      "unique_key": "DT1190197",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>The inferior mesenteric lymph nodes are not typically involved in the lymphatic drainage of endometrial carcinoma.</strong></li>\r\n<li>Endometrial cancer primarily spreads via specific lymphatic pathways. The lymphatic drainage of the uterus involves the <strong>para-aortic nodes</strong> (from the fundus/upper lymphatics), <strong>external and internal iliac nodes</strong>(from the body and cervix/middle and lower lymphatics), and <strong>superficial inguinal nodes</strong> (from the cornua).</li>\r\n<li>The inferior mesenteric nodes drain parts of the large intestine and are not part of the primary lymphatic drainage for the uterus.</li>\r\n<li><strong>Besides these other regional lymph node involved in CA endometrium are:</strong>\r\n<ul>\r\n<li>Parametrial LN</li>\r\n<li>Presacral LN</li>\r\n<li>Pelvic LN</li>\r\n<li>Obturator.</li>\r\n</ul>\r\n</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250902c6267a9f-3bb8-4e21-9a6b-a1139cbcb3b8.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Para-aortic (Option A):</strong> These lymph nodes are <strong>involved</strong>, specifically draining the upper lymphatics from the uterine fundus.</p>\r\n<p><strong>External iliac (Option B):</strong> These lymph nodes are <strong>involved</strong>, draining both the middle lymphatics from the uterine body and the lower lymphatics from the cervix.</p>\r\n<p><strong>Inguinal (Option D):</strong> Specifically, the <strong>superficial inguinal nodes</strong> are <strong>involved</strong>, draining lymph from the uterine cornua.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Endometrial cancer spreads to specific regional lymph nodes.</li>\r\n<li><strong>Para-aortic, external iliac, internal iliac, and superficial inguinal lymph nodes</strong> are all involved in the lymphatic drainage of the uterus.</li>\r\n<li>The <strong>inferior mesenteric lymph nodes</strong> are <strong>not part of the typical lymphatic drainage</strong> for endometrial cancer.</li>\r\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical involvement</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Lymph node involvement</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma in situ</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary serous tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are recognized indications for adjuvant radiotherapy in the management of endometrial carcinoma, except:</span></p>",
      "unique_key": "DT1190210",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Carcinoma in situ (CIS) of the endometrium is not typically an indication for adjuvant radiotherapy.</strong></li>\r\n<li>CIS represents non-invasive carcinoma confined to the endometrial glands without stromal invasion. While it indicates malignant potential, its management usually involves surgical removal (e.g., hysterectomy) without the need for additional adjuvant radiotherapy, unlike invasive carcinoma with high-risk features.</li>\r\n<li><strong>Indications of adjuvant radiotherapy:</strong>\r\n<ul>\r\n<li>Extrauterine extension.</li>\r\n<li>Lower uterine or cervical involvement.</li>\r\n<li>Papillary serous or clear cell histology.</li>\r\n<li>Poor histologic differentiation (Grade III).</li>\r\n<li>Myometrial penetration greater than 1/2 of thickening.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Cervical involvement (Option A):</strong> This is an <strong>indication for adjuvant radiotherapy</strong>. Lower uterine or cervical involvement signifies local spread beyond the endometrial lining and increases the risk of recurrence, thus warranting adjuvant radiation.</p>\r\n<p><strong>Lymph node involvement (Option B):</strong> This is a strong <strong>indication for adjuvant radiotherapy</strong>. Pelvic node involvement confirms regional spread and significantly increases the risk of recurrence, making adjuvant radiation a crucial part of treatment.</p>\r\n<p><strong>Papillary serous tumor (Option D):</strong> This is an <strong>indication for adjuvant radiotherapy</strong>. Papillary serous histology is a <strong>high-risk histological subtype</strong> of endometrial cancer, known for its aggressive behavior and high propensity for recurrence and metastasis, even at early stages. Therefore, adjuvant therapy, including radiotherapy, is commonly given.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Adjuvant radiotherapy in endometrial carcinoma is given for features indicating <strong>higher risk of recurrence or more advanced disease</strong>.</li>\r\n<li>Indications include <strong>extrauterine extension, lower uterine/cervical involvement, high-risk histologies (like papillary serous or clear cell), poor differentiation (Grade III), myometrial invasion (&gt;1/2 thickness), and pelvic node involvement</strong>.</li>\r\n<li><strong>Carcinoma in situ (CIS)</strong>, being non-invasive, <strong>does not typically require adjuvant radiotherapy</strong>.</li>\r\n</ul>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Penetration into half of myometrium</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Clear cell carcinoma</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Fundal involvement</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary serous carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an indication to perform lymph node dissection in a patient with endometrial carcinoma?</span></p>",
      "unique_key": "DT1190217",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190217,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Fundal involvement by itself is not a direct indication for lymph node dissection in endometrial carcinoma.</strong></li>\n<li>While the fundus is a common site for endometrial cancer, the decision for lymphadenectomy is primarily driven by other high-risk factors that indicate a greater likelihood of nodal metastasis.</li>\n</ul>\n<p><strong>Indications for Lymph Node (Pelvic and Para-aortic) Dissection in Endometrial Cancer</strong></p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509020abeaced-040c-4360-be7c-dfe6c2c2ed73.png\">\n<p><strong>Note:</strong> In absence of these factors only bilateral pelvic lymphadenectomy is performed if the tumor size is greater than 2 cm. Para aortic lymphadenectomy would be performed if pelvic lymph nodes are positive. Lymphadenectomy is altogether omitted for patients with above risk factors absent, absence of cervical involvement and tumor size less than 2 cm.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Lymph node dissection in endometrial carcinoma is performed based on factors indicating a <strong>higher risk of nodal metastasis</strong>.</li>\n<li><strong>Deep myometrial invasion, clear cell histology, and papillary serous histology</strong> are all direct indications for lymph node dissection.</li>\n<li><strong>Fundal involvement alone</strong> is not a primary indication, unlike the other high-risk features.</li>\n</ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Body habitus</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Level of CA-125</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Nutritional status</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Histologic type of tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 80-year-old female, with no history of estrogen use, develops a pink vaginal discharge. An endometrial biopsy confirms adenocarcinoma of the endometrium, while her Papanicolaou smear is negative. Of the following options, what is considered the most important indicator of prognosis in this patient?</span></p>",
      "unique_key": "DT1190222",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Among the given options, the <strong>histologic type of the tumor is the most important indicator of prognosis</strong> in endometrial adenocarcinoma.</li>\r\n<li>For instance, <strong>endometrioid adenocarcinoma generally has a good prognosis</strong>, whereas <strong>clear cell carcinoma carries a poor prognosis</strong>.</li>\r\n<li>This distinction is critical as different histological subtypes exhibit varying degrees of aggressiveness and metastatic potential.</li>\r\n<li><strong>Prognostic factors in endometrial adenocarcinoma:</strong>\r\n<ul>\r\n<li>Most important prognostic factor is lymph node metastasis</li>\r\n<li>Age at diagnosis (older the patient poorer the prognosis).</li>\r\n<li>Stage of the disease.</li>\r\n<li>Histologic type (endometrioid adenocarcinoma have good prognosis, clear cell carcinoma have poor prognosis).</li>\r\n<li>Histologic grade.</li>\r\n<li>Myometrial penetration (Increasing depth of invasion is associated with increasing likelihood of extrauterine spread and recurrence).</li>\r\n<li>Extension to cervixes Involvement of cervix, isthmus or both is associated with increased risk of extrauterine disease and LN metastasis.</li>\r\n<li>Tumor size (&gt; 2 cm&ndash;more lymph node metastasis).</li>\r\n<li>Hormone receptor status (receptor positive&ndash;better prognosis).</li>\r\n<li>Ploidy status: Aneuploid have got better prognosis compared to diploid tumors.</li>\r\n<li>Oncogene expression: HER: 2/neu, k-ras poor prognosis.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Body habitus (Option A):</strong> While obesity is a risk factor for developing endometrial cancer, it is <strong>not listed as the most important direct indicator of prognosis</strong> once the cancer is diagnosed, compared to tumor characteristics.</p>\r\n<p><strong>Level of CA-125 (Option B):</strong> CA-125 levels can be elevated in advanced endometrial cancer, and a high level might suggest more widespread disease. However, it is <strong>not identified as the most important prognostic factor</strong> in the provided text. The text primarily focuses on tumor characteristics like histologic type, grade, and stage.</p>\r\n<p><strong>Nutritional status (Option C):</strong> Nutritional status can influence overall patient health and tolerance to treatment, but it is <strong>not listed as a direct or the most important prognostic indicator</strong> for the cancer itself in the provided information on prognostic factors.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>histologic type of the tumor</strong> (e.g., endometrioid vs. clear cell carcinoma) is a <strong>major prognostic factor</strong> in endometrial adenocarcinoma.</li>\r\n<li>Other important prognostic factors include <strong>lymph node metastasis (most important overall), stage of the disease, histologic grade, depth of myometrial penetration, cervical involvement, tumor size, hormone receptor status, ploidy status, and oncogene expression</strong>.</li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Homologous sarcoma</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoma uterus</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed Mullerian carcinogenesis</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Heterologous sarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient is diagnosed with a uterine tumor that contains both adenocarcinoma and sarcoma components. What is this type of tumor known as?</span></p>",
      "unique_key": "DT1190224",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190224,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Mixed Mullerian carcinoma (MMC), </strong>also known <strong>as carcinosarcoma,</strong> is the term for a <strong>uterine tumor containing a mixture of both carcinomatous (adenocarcinoma) and sarcomatous elements</strong>.</li>\r\n<li>This type of tumor represents about 50% of all uterine sarcomas. The most common combination observed is serous carcinoma with an endometrial sarcoma component.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Homologous sarcoma (Option A):</strong> This term refers to a specific type of <strong>sarcomatous component within a mixed Mullerian tumor</strong> where the mesenchymal/sarcomatous differentiation mimics malignant endometrial or smooth muscle tissue. It does not describe the entire mixed tumor itself.</p>\r\n<p><strong>Sarcoma uterus (Option B):</strong> This is a <strong>general term for any malignant tumor of mesenchymal origin in the uterus</strong>. It does not specifically denote the presence of an adenocarcinoma component alongside the sarcoma.</p>\r\n<p><strong>Heterologous sarcoma (Option D):</strong> This term describes a specific type of <strong>sarcomatous component within a mixed Mullerian tumor</strong> if the sarcoma mimics extra-uterine tissues, such as striated muscle, cartilage, adipose tissue, or bone. It does not describe the overall tumor combining both carcinoma and sarcoma.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>A uterine tumor with both adenocarcinoma and sarcoma components is known as <strong>Mixed Mullerian carcinoma (or carcinosarcoma)</strong>.</li>\r\n<li>It is the <strong>most common histologic type of uterine sarcoma</strong>.</li>\r\n<li>The <strong>sarcomatous component</strong> can be <strong>homologous</strong> (resembling uterine tissue) or <strong>heterologous</strong> (resembling extra-uterine tissue).</li>\r\n</ul>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Metropathia hemorrhagica</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Gynandroblastoma</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysgerminoma</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions can cause endometrial cancer?</span></p>",
      "unique_key": "DT1190228",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190228,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Metropathia hemorrhagica is a causative factor for endometrial cancer.</strong></li>\r\n<li>It is synonymous with cystic glandular hyperplasia, a condition characterized by unopposed estrogen exposure, which promotes endometrial proliferation and increases the risk of malignant transformation.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Gynandroblastoma (Option B):</strong> This is a virilizing tumor that primarily secretes <strong>androgens</strong>, not estrogens. Since endometrial cancer is typically associated with unopposed estrogen, gynandroblastoma does not directly lead to it.</p>\r\n<p><strong>Dysgerminoma (Option C):</strong> This is a <strong>neutral tumor</strong> that does not secrete either male or female sex hormones. While it may secrete placental alkaline phosphatase, LDH, and BHCG, it does not lead to endometrial cancer through hormonal mechanisms.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Endometrial cancer is often linked to prolonged, unopposed estrogen exposure.</strong></li>\r\n<li><strong>Metropathia hemorrhagica (cystic glandular hyperplasia)</strong> is associated with unopposed estrogen and can cause endometrial cancer.</li>\r\n<li>Tumors like <strong>gynandroblastoma (androgen-secreting) and dysgerminoma (hormonally neutral)</strong> do not typically cause endometrial cancer through hormonal pathways.</li>\r\n</ul>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical adenomatous hyperplasia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrophic endometrium</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma in situ</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are considered precursors of endometrial carcinoma, except:</span></p>",
      "unique_key": "DT1190236",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190236,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Atrophic endometrium is generally not considered a precursor to endometrial carcinoma.</strong></li>\r\n<li>Atrophy refers to thinning and shrinkage of the endometrial lining due to lack of estrogen stimulation, commonly seen in postmenopausal women.</li>\r\n<li>It represents a quiescent state and does not inherently lead to malignant transformation.</li>\r\n<li>Premalignant Lesions of Endometrium are:\r\n<ul>\r\n<li>Simple hyperplasia: Endometrium is thick. The glands are dilated and have outpouching and invaginations. They are crowded and have irregular outlines. The stroma is more dense and cellular.</li>\r\n<li>Complex hyperplasia: Endometrium is thicker. The glands are crowded and arranged back to back with reduced stroma. Most glands have irregular outlines. There are papillary processes and intraluminal bridges within the glands. Epithelial pseudostratification is present.</li>\r\n<li>Atypical hyperplasia: The endometrial glands have cytologic atypia. The gland outlines are of complex hyperplasia in type. The nuclei of the glands show enlargement, irregular size and shape, hyperchromasia and coarse chromatin.</li>\r\n<li>Carcinoma-in-situ: Commonly describes a lesion with severe cytologic as well as architectural abnormalities of the glands.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Atypical adenomatous hyperplasia (Option A):</strong> This term is synonymous with <strong>atypical hyperplasia</strong>, which is a recognized <strong>premalignant lesion</strong> of the endometrium. It involves cytological atypia in the glandular cells along with architectural abnormalities.</p>\r\n<p><strong>Adenocarcinoma in situ (Option C):</strong> This term (or carcinoma in situ) describes a lesion with <strong>severe cytologic and architectural abnormalities of the glands</strong>. It is a direct precursor to invasive adenocarcinoma, representing full-thickness dysmaturity without invasion.</p>\r\n<p><strong>Cystic hyperplasia (Option D):</strong> This term is often synonymous with <strong>simple hyperplasia</strong>, which is considered a <strong>premalignant lesion</strong> of the endometrium. It is characterized by dilated, crowded, and irregularly outlined glands with increased stromal density.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Endometrial hyperplasia (simple, complex, atypical)</strong> and <strong>carcinoma in situ</strong> are all considered <strong>premalignant lesions</strong> of the endometrium.</li>\r\n<li><strong>Atypical adenomatous hyperplasia</strong> and <strong>cystic hyperplasia</strong> are included within these premalignant categories.</li>\r\n<li><strong>Atrophic endometrium</strong> is typically a benign, quiescent state and <strong>not a precursor</strong> to endometrial carcinoma.</li>\r\n</ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy + Radiotherapy</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">No treatment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the recommended choice of adjuvant treatment for a patient diagnosed with endometrial carcinoma, Stage IA Grade I?</span></p>",
      "unique_key": "DT1190238",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190238,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>No adjuvant treatment is typically required for endometrial carcinoma Stage IA Grade I.</strong> For patients with Stage IA Grade I and even Grade II endometrial carcinoma, post-operative observation without additional treatment is the standard approach.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Radiotherapy (Option A):</strong> Adjuvant radiotherapy is generally reserved for higher-risk stages or features in endometrial cancer, not for Stage IA Grade I.</p>\r\n<p><strong>Chemotherapy (Option B):</strong> Chemotherapy is used for more advanced stages of endometrial carcinoma or specific aggressive subtypes, not for early-stage, low-grade disease like Stage IA Grade I.</p>\r\n<p><strong>Chemotherapy + Radiotherapy (Option C):</strong> This combined approach is reserved for very high-risk or advanced endometrial cancer cases, far beyond the needs of Stage IA Grade I.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Stage IA Grade I endometrial carcinoma</strong> typically has an excellent prognosis.</li>\r\n<li>For this specific stage and grade, <strong>no post-operative adjuvant treatment is usually required</strong>.</li>\r\n<li>Adjuvant therapies like radiotherapy or chemotherapy are indicated for <strong>higher-risk stages or histological features</strong>.</li>\r\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Low parity</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\"> Multiple sexual partner</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Early sexual intercourse (< 16 years)</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Smoking</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a recognized risk factor for cervical carcinoma (Ca cervix)?</span></p>",
      "unique_key": "DT1190949",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190949,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Low parity (Option A) is not a risk factor for cervical carcinoma; in fact, multiparity (having many children) is listed as a predisposing factor</strong>.</li>\n<li>The increased risk with multiparity is thought to be related to cervical trauma during childbirth, hormonal changes, or increased exposure to HPV. Therefore, low parity would logically not be a risk factor.</li>\n<li>Factors Predisposing to CIN/Ca cervix:\n<ul>\n<li>Human Papillomavirus infection</li>\n<li>Sexually transmitted infection</li>\n<li>Coitus before 18 years of age <strong>(Option C ruled out)</strong></li>\n<li>Multiple sex partners <strong>(Option B ruled out)</strong></li>\n<li>Multiparity</li>\n<li>Poor personal hygiene</li>\n<li>Poor socioeconomic status</li>\n<li>Smoking <strong>(Option D ruled out)</strong></li>\n<li>Immunosuppressed individuals</li>\n<li>Women on OCP, Progesterone therapy for a long time are predisposed to adenocarcinoma of endocervix.</li>\n<li>In utero exposure to DES</li>\n<li>HPV is central to the development of cervical neoplasia. HPV - DNA is found in 95% of all squamous cell carcinoma &amp; 90% of all adenocarcinomas.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>HPV infection</strong> is the <strong>central risk factor</strong> for cervical neoplasia.</li>\n<li>Other significant risk factors include <strong>multiple sexual partners, early sexual intercourse, and smoking</strong>.</li>\n<li><strong>Multiparity</strong>, not low parity, is associated with an increased risk of cervical cancer.</li>\n</ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Irregular vaginal bleeding</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-coital bleeding</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Foul-smelling discharge</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is considered the earliest symptom of carcinoma cervix?</span></p>",
      "unique_key": "DT1190951",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190951,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The <strong>earliest symptom of invasive cervical carcinoma is usually abnormal vaginal bleeding</strong>.</li>\r\n<li>This often presents as irregular uterine bleeding or discharge, or both. While the first episode of bleeding commonly follows coitus, <strong>irregular vaginal bleeding encompasses this and other forms of abnormal bleeding</strong>, making it the broader and earliest general symptom.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Post-coital bleeding (Option B):</strong> This is a very common and concerning early symptom, often being the <strong>first episode of bleeding</strong>. However, irregular vaginal bleeding is a more encompassing term for the earliest manifestation of abnormal bleeding.</p>\r\n<p><strong>Foul-smelling discharge (Option C):</strong> While foul-smelling vaginal discharge may be associated with early-stage cervical cancer, it is often noted <strong>alongside or after bleeding</strong>, making irregular bleeding typically the earliest symptom.</p>\r\n<p><strong>Pain (Option D):</strong> Pain is generally a <strong>late symptom</strong> of cervical cancer, indicating more advanced disease where the tumor has spread beyond the cervix. Early-stage carcinoma cervix is usually asymptomatic.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Early-stage invasive cervical carcinoma is often <strong>asymptomatic</strong>.</li>\r\n<li>When symptoms appear, the <strong>earliest is typically irregular vaginal bleeding</strong>.</li>\r\n<li>This bleeding often <strong>follows coitus</strong>, but can also occur intermittently or be blood-tinged discharge.</li>\r\n<li><strong>Pain</strong> is a <strong>late symptom</strong>.</li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Septicemia</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\"> Uremia</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Raised ICT (Intracranial Tension) </span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with carcinoma of the cervix presents with altered sensorium and hiccups. What is the likely cause of these symptoms?</span></p>",
      "unique_key": "DT1190953",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In a case of carcinoma cervix with altered sensorium and hiccups, <strong>uremia is the likely cause</strong>.</li>\r\n<li><strong>Uremia</strong> refers to the accumulation of urea and other nitrogenous waste products in the blood due to <strong>renal failure</strong>.</li>\r\n<li>In carcinoma cervix, this commonly occurs when the tumor <strong>involves and blocks the ureter</strong>, leading to kidney dysfunction. <strong>Hiccups and altered sensorium are non-specific signs of uremia</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Septicemia (Option A):</strong> While infection can be a complication in advanced cancer, septicemia typically presents with fever, chills, and signs of systemic infection, which are not specifically highlighted as the primary cause of altered sensorium and hiccups in this context.</p>\r\n<p><strong>Raised ICT (Intracranial Tension) (Option C):</strong> Raised ICT, often due to brain metastases, can cause altered sensorium. However, hiccups are less commonly a prominent symptom of raised ICT compared to uremia in cancer patients, and the explanation specifically points to uremia as the cause in this scenario.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Uremia is a significant complication and common cause of death in carcinoma cervix</strong>, primarily due to <strong>ureteral involvement and subsequent renal failure</strong>.</li>\r\n<li><strong>Hiccups and altered sensorium are non-specific signs that can indicate uremia</strong> in patients with carcinoma cervix.</li>\r\n<li><strong>Renal failure/uremia is the most common cause of death</strong> in cancer cervix, followed by hemorrhage.</li>\r\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Common at squamocolumnar junction</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\"> CT scan is mandatory for staging</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-coital bleeding is a common symptom</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">HPV 16 and 18 are associated with a high risk of carcinogenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about squamous cell carcinoma of the cervix is false?</span></p>",
      "unique_key": "DT1190961",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190961,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>The statement that CT scan is mandatory for staging of squamous cell carcinoma of the cervix is false.</strong></li>\r\n<li>While imaging techniques like CT scans are useful for assessing the extent of the disease and guiding treatment, they are <strong>not mandatory for the primary FIGO clinical staging</strong> of cervical cancer. FIGO staging of cervical cancer is primarily a clinical staging system.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Common at squamocolumnar junction (Option A):</strong> Squamous cell carcinoma of the cervix most commonly arises at the <strong>squamocolumnar junction</strong> (also known as the transformation zone).</p>\r\n<p><strong>Post-coital bleeding is a common symptom (Option C):</strong> Post-coital bleeding is a <strong>common and often early symptom</strong> of cervical carcinoma.</p>\r\n<p><strong>HPV 16 and 18 are associated with high risk of carcinogenesis (Option D):</strong> HPV 16 and HPV 18 are categorized as <strong>High-Risk HPV types</strong> and are strongly associated with the carcinogenesis of cervical cancer. HPV DNA is found in a high percentage of both squamous cell carcinomas and adenocarcinomas.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Squamous cell carcinoma of the cervix commonly arises at the squamocolumnar junction.</strong></li>\r\n<li><strong>HPV 16 and 18 are high-risk types strongly linked to cervical carcinogenesis.</strong></li>\r\n<li><strong>Post-coital bleeding is a frequent symptom.</strong></li>\r\n<li><strong>CT scans are useful but not mandatory for primary FIGO clinical staging</strong> of cervical cancer.</li>\r\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Wertheim's hysterectomy</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Conization</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait and watch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman, G3P3, attends a clinic for follow-up after an abnormal cervical biopsy. She is asymptomatic but had a Pap smear showing High-Grade Squamous Intraepithelial Lesion (HSIL). Colposcopy-directed biopsy confirms carcinoma in situ (CIN III). What is the most appropriate next step in management for this patient ?</span></p>",
      "unique_key": "DT1190968",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190968,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>For a 42-year-old multiparous woman (P3L3) diagnosed with <strong>carcinoma in situ (CIN III)</strong>, <strong>simple hysterectomy is considered the most appropriate treatment, especially if she has completed her family</strong>.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Wertheim's hysterectomy (Option B):</strong> Wertheim's hysterectomy is a <strong>radical hysterectomy</strong> performed for <strong>invasive cervical cancer</strong>, not for carcinoma in situ. This extensive surgery is overly aggressive for CIN III.</p>\r\n<p><strong>Conization (Option C):</strong> Conization (cone biopsy) is a valid treatment for carcinoma in situ, especially for <strong>younger women who wish to preserve fertility</strong>. However, for a 42-year-old P3L3, hysterectomy is generally considered definitive and preferable if fertility is not a concern.</p>\r\n<p><strong>Wait and watch (Option D):</strong> Carcinoma in situ (CIN III) is a <strong>high-grade precancerous lesion with a significant risk of progression to invasive cancer</strong>. Therefore, a \"wait and watch\" approach is <strong>not appropriate</strong> and active treatment is indicated.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Carcinoma in situ (CIN III)</strong> requires active treatment due to its potential for progression.</li>\r\n<li>For <strong>older women or those who have completed childbearing (like a 42-year-old G3P3)</strong>, <strong>simple hysterectomy is a highly effective and often preferred treatment</strong>.</li>\r\n<li><strong>Conization</strong> is an alternative, particularly for <strong>fertility preservation</strong>.</li>\r\n</ul>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Conization</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Laser</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple hysterectomy</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Modified Radical hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the context of microinvasive cervical cancer, what is considered the most common treatment approach?</span></p>",
      "unique_key": "DT1190974",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190974,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>For <strong>microinvasive cervical cancer</strong>, defined as less than 3mm stromal invasion with no lymphatic or vascular involvement, <strong>simple hysterectomy is the most common treatment</strong>. This procedure effectively removes the entire uterus and cervix, providing definitive treatment for this early stage of invasion.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240425c0120e5a-d946-4bd6-b0b7-b3150d1d0655.jpg\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Conization (Option A):</strong> While conization can be used for very early microinvasive disease, especially in women desiring fertility preservation, <strong>simple hysterectomy</strong> is generally considered the more common and definitive treatment.</p>\r\n<p><strong>Laser (Option B):</strong> Laser ablation or excision can be used for high-grade dysplasia (CIN) and very select cases of microinvasive disease, but it's <strong>less common as the primary treatment for microinvasive cancer</strong> compared to hysterectomy, especially if fertility preservation is not the primary goal.</p>\r\n<p><strong>Modified Radical hysterectomy (Option D):</strong> Modified radical hysterectomy is typically reserved for <strong>more advanced stages of invasive cervical cancer</strong> where there is deeper invasion or greater spread, not for microinvasive disease.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Microinvasive cervical cancer</strong> involves less than 3mm stromal invasion without lymphatic/vascular involvement.</li>\r\n<li><strong>Simple hysterectomy</strong> is the <strong>most common treatment</strong> for this stage.</li>\r\n<li>Conization may be an option for fertility preservation in highly selected cases.</li>\r\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy is helpful in all stages</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Prognosis of surgery good if done in early stages</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">When radiotherapy is given, para-aortic lymph nodes should always be included. </span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy is reserved for late stages</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about the treatment of cervical carcinoma (Ca cervix) is false?</span></p>",
      "unique_key": "DT1190978",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190978,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The statement that <strong>para-aortic lymph nodes should always be included when radiotherapy is given for cervical cancer is false.</strong></li>\r\n<li>Routine radiotherapy for cervical cancer does <strong>not routinely include para-aortic lymph nodes</strong>.</li>\r\n<li>Extended field radiotherapy to include para-aortic lymph nodes is only given if there is <strong>documented involvement of these nodes</strong>, due to the increased risk of enteric morbidity.</li>\r\n<li>IOC to know whether para-aortic lymph nodes are evolved is PET/CT imaging studies.</li>\r\n<li>Radiotherapy for para aortic lymph nodes leads to bowel complications and to avoid these complications, extra peritoneal dissection of para aortic nodes is recommended and the dose of radiation should be reduced to 5000 cGy or less. When this approach is used, post radiotherapy bowel complications occur in &lt; 5% patients and 5 year survival rate is 15-26% in patients with positive para aortic nodes</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Radiotherapy is helpful in all stages (Option A):</strong> Radiotherapy plays a crucial role in the management of cervical cancer, being used in early stages (as an alternative to surgery), locally advanced stages (concurrently with chemotherapy), and even in palliative settings for advanced disease.</p>\r\n<p><strong>Prognosis of surgery good if done in early stages (Option B):</strong> Surgical treatment, such as radical hysterectomy, offers an excellent prognosis for <strong>early-stage cervical cancer</strong>.</p>\r\n<p><strong>Chemotherapy is reserved for late stages (Option D):</strong> Chemotherapy, often concurrent with radiotherapy, is primarily used for <strong>locally advanced or metastatic (late-stage)</strong> cervical cancer to improve outcomes.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Routine radiotherapy for cervical cancer does not automatically include para-aortic lymph nodes.</strong></li>\r\n<li><strong>Para-aortic lymph nodes are included only if they are documented to be involved</strong>, typically confirmed by imaging like PET/CT.</li>\r\n<li><strong>Radiotherapy is effective across various stages</strong>, and <strong>surgery yields good prognosis in early stages</strong>.</li>\r\n<li><strong>Chemotherapy is mainly for advanced disease</strong>.</li>\r\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Wertheim procedure</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Schauta's procedure</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Intracavitary brachytherapy followed  by  external beam RT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most appropriate treatment for Stage IIIB carcinoma of the cervix?</span></p>",
      "unique_key": "DT1190981",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190981,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Radiotherapy for locally advanced cervical cancer generally involves a combination of <strong>external beam radiation therapy (EBRT) and brachytherapy (intracavitary)</strong>.</li>\r\n<li>While typically EBRT precedes brachytherapy, the sequence in option D (intracavitary brachytherapy followed by external beam RT) is also a form of comprehensive radiotherapy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Wertheim procedure (Option A):</strong> The Wertheim procedure is a <strong>radical hysterectomy</strong>, which is a surgical treatment suitable for <strong>early-stage (Stage I or select Stage IIA)</strong> cervical cancer, not for Stage IIIB disease.</p>\r\n<p><strong>Schauta's procedure (Option B):</strong> Schauta's procedure is a <strong>vaginal radical hysterectomy</strong>, also reserved for <strong>early-stage cervical cancer</strong> and not appropriate for locally advanced disease like Stage IIIB.</p>\r\n<p><strong>Chemotherapy (Option C):</strong> While chemotherapy is an important component of concurrent chemoradiation for Stage IIIB, <strong>chemotherapy alone is not sufficient</strong> as the primary treatment for locally advanced cervical cancer.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The definitive treatment for <strong>Stage IIIB cervical carcinoma</strong> is primarily <strong>radiotherapy, often combined concurrently with chemotherapy</strong>.</li>\r\n<li>Radiotherapy involves a combination of <strong>external beam and brachytherapy</strong>.</li>\r\n<li>Surgical procedures like Wertheim's or Schauta's hysterectomy are for <strong>earlier stages</strong>.</li>\r\n<li><strong>Chemotherapy alone is insufficient</strong> for primary treatment of Stage IIIB.</li>\r\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Staging should be done after cystoscopy.</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">It is classified as Stage IIB. </span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy should be given</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterectomy can be useful</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is false regarding carcinoma of the cervix involving the parametrium but without pelvic wall involvement?</span></p>",
      "unique_key": "DT1190983",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190983,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>The statement that <strong>hysterectomy can be useful for carcinoma cervix involving the parametrium but not the pelvic wall is false.</strong></li>\r\n<li>This presentation describes <strong>Stage IIB cervical cancer</strong>. For Stage IIB, <strong>radical hysterectomy (Wertheim's hysterectomy) is generally not performed</strong>. The management of choice for Stage IIB is <strong>chemoradiation</strong>, not surgery.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Staging should be done after cystoscopy (Option A):</strong> Procedures for surgical staging of cervical cancer, as advised by FIGO, <strong>include cystoscopy</strong>, which should be performed before final staging.</p>\r\n<p><strong>Stage IIB (Option B):</strong> Carcinoma of the cervix involving the <strong>parametrium but not extending to the pelvic wall</strong> is precisely defined as <strong>Stage IIB</strong>.</p>\r\n<p><strong>Radiotherapy should be given (Option C):</strong> As mentioned, <strong>radiotherapy (often combined with chemotherapy)</strong> is the <strong>management of choice</strong> for Stage IIB cervical cancer.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Carcinoma cervix involving the <strong>parametrium without pelvic wall involvement is Stage IIB</strong>.</li>\r\n<li>The primary treatment for Stage IIB is <strong>chemoradiation</strong>.</li>\r\n<li><strong>Surgery (radical hysterectomy) is not typically performed for Stage IIB</strong> cervical cancer.</li>\r\n<li><strong>Cystoscopy</strong> is part of the staging workup for cervical cancer.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509023ec0d8aa-329c-47cd-b80e-d2c727113e00.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090204b0d343-ecb5-4a8f-a742-18686e0ab77f.png\">",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical stenosis</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Infection</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Spread of malignancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cervical cone biopsy, when performed in a case of carcinoma cervix, can cause all of the following complications, except:</span></p>",
      "unique_key": "DT1190984",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190984,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Spread of malignancy is generally not a known complication of a properly performed cervical cone biopsy for carcinoma cervix.</strong></li>\r\n<li>Cone biopsy is a diagnostic and therapeutic procedure designed to remove the lesion entirely and obtain tissue for histological evaluation, thereby treating localized malignancy or precancerous lesions. While there are potential risks, the procedure itself is not typically associated with spreading the cancer.</li>\r\n<li>Cone biopsy is used as a treatment for cervical cancer - Stage IA1 for women whose family is not complete.</li>\r\n<li>Cone biopsy should be done under general anaesthesia.</li>\r\n<li>The cone should include the entire outer margin and the endocervical lining but internal OS is spared. A small cone is preferred in younger women to avoid pregnancy complications.</li>\r\n<li><strong>Complications of Cone biopsy are:</strong>\r\n<ul>\r\n<li>Hemorrhage <strong>(Option A ruled out)</strong></li>\r\n<li>Sepsis (infection) <strong>(Option C ruled out)</strong></li>\r\n<li>Cervical stenosis <strong>(Option B ruled out)</strong></li>\r\n<li>Pregnancy complications which include: - Mid trimester abortions\r\n<ul>\r\n<li>Preterm labour</li>\r\n<li>Cervical dystocia</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Common complications of cervical cone biopsy include hemorrhage, infection (sepsis), and cervical stenosis</strong>.</li>\r\n<li>Cone biopsy can also lead to <strong>pregnancy complications</strong> such as mid-trimester abortions, preterm labor, and cervical dystocia.</li>\r\n<li><strong>Spread of malignancy is not a typical complication</strong> of a cone biopsy, as the procedure aims to remove or diagnose the lesion.</li>\r\n</ul>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete fixity of cervix and parametrium to lateral pelvic wall </span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of extgrapelvic metastasis</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Involvement of bladder</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">None</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old postmenopausal woman presents to the gynecology OPD with complaints of foul-smelling vaginal discharge, pelvic pain for the past 3 months. On per speculum examination, a large ulceroproliferative growth is seen replacing the cervix. On bimanual examination, the cervix is fixed, and the parametrium feels indurated and extends up to the lateral pelvic wall. Cystoscopy reveals mucosal involvement of the urinary bladder, and CT imaging shows enlarged para-aortic lymph nodes along with a suspicious lesion in the liver. Which of the following findings would not be considered a sign of inoperability in this patient with carcinoma cervix?</span></p>",
      "unique_key": "DT1190990",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The answer is <strong>D) None</strong> because all the options listed (A, B, and C) are indeed signs of <strong>inoperable cervical cancer</strong>.</p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040141bce81e-8c15-4c3d-ab4f-bd8e48b3a4de.jpg\">\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Signs of <strong>inoperable cervical cancer</strong> include <strong>extensive local spread</strong> (e.g., complete fixity to pelvic wall, extensive infiltration of vagina or bladder) and <strong>distant metastasis</strong>.</li>\r\n<li>Other signs not listed in the options but indicative of inoperability include <strong>extensive infiltration of the vagina</strong>, and presence of <strong>vesicovaginal fistula (VVF)</strong>.</li>\r\n</ul>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">7000 cGy</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">6000 cGy</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">2000 cGy</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">10,000 cGy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Point B in the treatment of carcinoma cervix receives the dose of: </span></p>",
      "unique_key": "DT1190993",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190993,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In the radiotherapy for carcinoma cervix, <strong>Point B</strong> is a critical reference point for dosimetry. Point B is located <strong>2 cm above and 5 cm lateral to the external os</strong>.</li>\r\n<li>This point represents the dose received by the <strong>obturator lymph node</strong>. The dose of radiation typically received at Point B ranges from <strong>4000-6000 cGy</strong>. Among the given options, <strong>6000 cGy</strong> falls within this range and is a commonly targeted dose for Point B.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024040114f025c2-5825-446e-96dc-91055a62644d.jpg\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>7000 cGy (Option A):</strong> This dose (or 7000-8000 cGy) is typically prescribed for <strong>Point A</strong>, which is located 2 cm above and 2 cm lateral to the external os, representing the paracervical/parametrial lymph nodes.</p>\r\n<p><strong>2000 cGy (Option C):</strong> This dose is <strong>too low</strong> for Point B in radical treatment of cervical cancer. The range for Point B is 4000-6000 cGy, indicating 2000 cGy would be insufficient.</p>\r\n<p><strong>10,000 cGy (Option D):</strong> This is an <strong>excessively high dose</strong> for either Point A or Point B in standard combined external beam and brachytherapy regimens for cervical cancer and would lead to significant toxicity.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>In cervical cancer radiotherapy, <strong>Point A</strong> is located 2 cm above and 2 cm lateral to the external os, targeting paracervical/parametrial lymph nodes, with a dose of <strong>7000-8000 cGy</strong>.</li>\r\n<li><strong>Point B</strong> is located 2 cm above and 5 cm lateral to the external os, targeting the obturator lymph node, with a dose of <strong>4000-6000 cGy</strong>, with <strong>6000 cGy</strong> being a common target.</li>\r\n<li>Understanding these points and their respective doses is crucial for proper treatment planning and delivery in cervical cancer.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509027d9e5718-ec90-435a-8c7e-d2ecb49ddf19.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250902c7b72932-2b33-4fee-b913-3354ad5989d8.png\">",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Conventional pap smear</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid based cytology</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Hybrid capture 2 for HPV DNA</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Colposcopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">HPV triage strategy includes all except: </span></p>",
      "unique_key": "DT1190998",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190998,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Colposcopy</strong> is <strong>not a triage strategy</strong> but rather a <strong>diagnostic procedure</strong>.</li>\r\n<li>It is performed if abnormal cytology or persistent high-risk HPV is found during screening.</li>\r\n<li>HPV triage strategies are used to determine the next step in cervical cancer screening when HPV is detected.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Conventional Pap smear (Option A): </strong>This is used for <strong>cytological evaluation of cervical cells</strong> as part of HPV triage strategies.</p>\r\n<p><strong>Liquid based cytology (Option B): </strong>This is a more advanced method of cytology that <strong>improves sample quality</strong> and is included in HPV triage.</p>\r\n<p><strong>Hybrid capture 2 (HC2) for HPV DNA (Option C):</strong> This is a <strong>molecular test</strong> used to <strong>detect high-risk HPV DNA</strong> and is a key component of HPV triage strategies.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>HPV triage strategies involve tests to guide further management after HPV detection.</li>\r\n<li>Common triage components include <strong>conventional Pap smear</strong>, <strong>liquid-based cytology</strong>, and <strong>Hybrid Capture 2 for HPV DNA</strong>.</li>\r\n<li><strong>Colposcopy</strong> is a <strong>diagnostic follow-up procedure</strong>, not a triage test itself.</li>\r\n</ul>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical hysterectomy is not indicated for stage Ia disease, if the excision margins are free of the disease </span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI imaging is safe for staging even during pregnancy </span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical trachelectomy and pelvic lymphadenectomy can be done for stage IIa disease </span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy rate is about 35% within 1 year following radical trachelectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Concerning invasive cervical carcinoma, all are correct except: </span></p>",
      "unique_key": "DT1191001",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191001,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Radical trachelectomy and pelvic lymphadenectomy can be done for stage IIa disease is false.</strong></li>\r\n<li>Radical trachelectomy is indicated for <strong>early stage disease (Stage IA1, A2, IB1)</strong> and a <strong>small tumor volume (&lt; 2 cm)</strong>, primarily for fertility preservation in young women.</li>\r\n<li>It is <strong>not performed for Stage IIA disease</strong>, which involves invasion beyond the uterus but not to the parametrium.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Radical hysterectomy is not indicated for stage Ia disease, if the excision margins are free of the disease (Option A):</strong> For Stage IA cervical cancer, especially with clear margins, the treatment of choice is typically <strong>conization in young females or simple hysterectomy in older females</strong>. Radical hysterectomy is <strong>not performed in Stage IA</strong>.</p>\r\n<p><strong>MRI imaging is safe for staging even during pregnancy (Option B):</strong> MRI is considered a <strong>safe investigation during pregnancy</strong>, making it a suitable imaging modality for staging cervical cancer that occurs during pregnancy.</p>\r\n<p><strong>Pregnancy rate is about 35% within 1 year following radical trachelectomy (Option D):</strong> Radical trachelectomy aims to preserve fertility, and a pregnancy rate of about <strong>35% within 1 year</strong> following the procedure is reported.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Radical trachelectomy</strong> is a fertility-preserving surgery for <strong>early-stage (IA1, A2, IB1)</strong>, small-volume cervical cancer, but <strong>not for Stage IIA disease</strong>.</li>\r\n<li><strong>Radical hysterectomy</strong> is generally <strong>not indicated for Stage IA</strong> cervical cancer.</li>\r\n<li><strong>MRI is safe for staging cervical cancer during pregnancy</strong>.</li>\r\n<li>A reasonable <strong>pregnancy rate</strong> (around 35% in 1 year) can be expected following radical trachelectomy.</li>\r\n</ul>",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">I</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">II</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">III</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Involvement of pelvis in a case of vaginal carcinoma indicates which stage? </span></p>",
      "unique_key": "DT1191005",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Involvement of the pelvis in a case of vaginal carcinoma indicates <strong>Stage III</strong> disease. As per the provided \"Vaginal cancer staging\" table, <strong>Stage III</strong> is defined as \"Carcinoma extends up to the pelvic walls\".</p><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509021035b7e6-1397-40c5-a54a-967e17b2c70a.png\"><p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Vaginal cancer staging defines progression based on local and distant spread.</li>\r\n<li><strong>Stage III vaginal carcinoma</strong> is characterized by <strong>extension to the pelvic walls</strong>.</li>\r\n<li>The most common histologic type is squamous cell carcinoma, often found in the upper third of the posterior wall of the vagina.</li>\r\n<li>Lymphatic drainage varies by tumor location: upper vaginal tumors drain to pelvic lymph nodes, while lower vaginal tumors drain to inguinal lymph nodes.</li>\r\n</ul>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Vulval intraepithelial neoplasia</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Bowen's disease</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">All of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about Ca vulva associated/predisposed by:</span></p>",
      "unique_key": "DT1191012",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191012,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>All of above (Option D)</strong> is the correct answer because Paget's disease, Vulval intraepithelial neoplasia (VIN), and Bowen's disease are all recognized as <strong>premalignant lesions of the vulva</strong> or conditions associated with an increased risk of developing vulvar carcinoma.</li>\r\n<li>Premalignant lesion of vulva:\r\n<ul>\r\n<li>Vulvar intraepithelial neoplasia VIN (most common) <strong>(Option B rule out)</strong></li>\r\n<li>Paget's disease: An intraepithelial adenocarcinoma that is frequently associated with an underlying invasive vulvar carcinoma <strong>(Option A ruled out)</strong></li>\r\n<li>Bowen's disease: It is a type of squamous cell carcinoma in situ, is also a premalignant condition that can progress to invasive vulvar cancer. <strong>(Option C ruled out)</strong></li>\r\n<li>Chronic vulvar dystrophies</li>\r\n<li>Condyloma accuminata</li>\r\n<li>Lichen sclerosis Squamous cell hyperplasia</li>\r\n<li>Erythroplasia of Queyrat</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Vulvar carcinoma can be predisposed by or associated with several <strong>premalignant lesions</strong>.</li>\r\n<li>Key premalignant conditions include <strong>Vulval Intraepithelial Neoplasia (VIN)</strong> (most common), <strong>Paget's disease</strong>, <strong>Bowen's disease</strong>, chronic vulvar dystrophies (like lichen sclerosis and squamous cell hyperplasia), and erythroplasia of Queyrat.</li>\r\n</ul>",
      "correct_choice_id": 284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous hyperplasia predisposes</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Paget's disease of vulva predisposes</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Lichen sclerosis & Condylomata acuminata</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">All of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vulval Ca, True statements: </span></p>",
      "unique_key": "DT1191017",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191017,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>All of the above </strong>is the correct answer because squamous hyperplasia, Paget's disease of vulva, lichen sclerosis, and condylomata acuminata are all associated with or predisposed to vulvar carcinoma.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509025678017c-fe12-4cc9-8dca-7a0e325bcb46.png\"><p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Squamous hyperplasia predisposes (Option A):</strong> Squamous hyperplasia (formerly hyperplastic dystrophy) is recognized as a <strong>non-neoplastic epithelial disorder</strong> that can predispose to vulvar cancer, especially when concomitant with lichen sclerosis, indicating a high-risk scenario.</p>\r\n<p><strong>Paget's disease of vulva predisposes (Option B):</strong> Paget's disease is classified under <strong>non-squamous intraepithelial neoplasia</strong> and is a known <strong>premalignant condition</strong> of the vulva.</p>\r\n<p><strong>Lichen sclerosis &amp; Condylomata acuminata (Option C):</strong></p>\r\n<p><strong>Lichen sclerosis</strong> is a <strong>non-neoplastic epithelial disorder</strong> with malignant potential, particularly when associated with concomitant hyperplasia.</p>\r\n<p><strong>Condylomata acuminata</strong> (vulvar warts) are caused by HPV types 6 and 11. While these types are typically low-risk, their presence indicates HPV infection which can be associated with an increased risk of vulvar malignancy, especially if high-risk HPV types are also present or if there is associated VIN.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Vulvar cancer can arise from or be predisposed by a range of epithelial disorders.</li>\r\n<li><strong>Premalignant lesions</strong> include Vulval Intraepithelial Neoplasia (VIN) types, <strong>Paget's disease</strong>, and <strong>Bowen's disease</strong>.</li>\r\n<li><strong>Non-neoplastic epithelial disorders</strong> like <strong>Lichen sclerosis</strong> and <strong>squamous hyperplasia</strong> also carry a risk, particularly when mixed or high-risk features are present.</li>\r\n<li><strong>Condylomata acuminata</strong> (HPV-induced warts) are also part of the broader spectrum of conditions associated with vulvar health and potential malignancy risk.</li>\r\n</ul>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">Spreads to superficial inguinal nodes & Spreads to iliac nodes</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">Seen after menopause</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral predisposition</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">All</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about carcinoma vulva:</span></p>",
      "unique_key": "DT1191028",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191028,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>All (Option D)</strong> is the correct answer because carcinoma vulva is accurately described by all the individual statements: it spreads to superficial inguinal and then iliac nodes, is commonly seen after menopause, and has a viral predisposition.</li>\r\n<li>Vulval cancer is a relatively uncommon malignancy, accounting for <strong>2-4% of all female genital tract cancers</strong>.</li>\r\n<li>It predominantly affects <strong>older women</strong>, typically occurring in the <strong>6th or 7th decade of life</strong>.</li>\r\n<li>The <strong>most common histological type is epidermoid (squamous cell) carcinoma</strong>, seen in about 90% of cases.</li>\r\n<li>The <strong>most common site is the labia majora</strong> (anterior 2/3rd), followed by the clitoris and labia minora.</li>\r\n<li>It has a <strong>viral predisposition</strong>, similar to carcinoma in situ of the cervix, linked to viruses such as <strong>HIV, HPV, and HSV-II</strong>.</li>\r\n<li><strong>Lymphatic spread</strong> is the primary mode of dissemination. It first involves <strong>superficial inguinal nodes</strong>, then spreads to <strong>deep nodes</strong>, and subsequently to <strong>external iliac, obturator, and common iliac nodes in late stages</strong>.</li>\r\n<li><strong>Lymph node involvement is the single most important prognostic factor</strong>, with the presence of inguinal lymph node metastasis reducing overall survival by 50%.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Vulval cancer typically affects <strong>post-menopausal women</strong>.</li>\r\n<li>Its spread pattern involves <strong>regional lymph nodes</strong>, starting with <strong>inguinal nodes</strong> and potentially progressing to <strong>iliac nodes</strong>.</li>\r\n<li>There is a significant <strong>viral predisposition</strong>, notably by <strong>HPV</strong>.</li>\r\n<li><strong>Lymph node involvement</strong> is the <strong>most crucial prognostic factor</strong>.</li>\r\n</ul>",
      "correct_choice_id": 304,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage Ib Ca cervix</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian Ca</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage IV Ca vagina</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage II fallopian tube Ca</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Brachytherapy is used in:</span></p>",
      "unique_key": "DT1191031",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Stage Ib Ca cervix (Option A)</strong> is a correct indication for brachytherapy. For <strong>Stage IB and IIA</strong> cervical cancer, both surgery and radiotherapy (which includes brachytherapy) yield similar results.</li>\r\n<li>Brachytherapy is a common component of radiotherapy for cervical cancer, particularly used for larger tumors (after external radiation) or first in smaller tumors (followed by external radiation).</li>\r\n<li>Radiotherapy is a recommended treatment for advanced stages of cervical carcinoma (e.g., Stage IIB onwards).</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Ovarian Ca (Option B):</strong> There is <strong>very little scope for radiotherapy in ovarian tumors</strong>. Only specific types like Granulosa cell tumor and dysgerminoma are radiosensitive, and even then, external radiotherapy is usually instituted for elderly women, not typically brachytherapy.</p>\r\n<p><strong>Stage IV Ca vagina (Option C):</strong> Vaginal squamous cell carcinoma is <strong>only moderately sensitive to irradiation</strong>. In advanced cases like Stage IV, <strong>exenteration operation</strong> is often performed, rather than primary brachytherapy alone.</p>\r\n<p><strong>Stage II fallopian tube Ca (Option D):</strong> The primary treatment for fallopian tube carcinoma, including Stage II, involves <strong>Total Hysterectomy with Bilateral Salpingo-oophorectomy along with omentectomy</strong>, followed by <strong>external pelvic radiation</strong>. Brachytherapy is not typically listed as a primary modality here.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Brachytherapy is a cornerstone of radiotherapy for cervical cancer</strong>, especially in early to moderately advanced stages (e.g., Stage IB, IIA).</li>\r\n<li>Radiotherapy has <strong>limited scope in ovarian cancers</strong>, primarily used for specific radiosensitive types.</li>\r\n<li><strong>Vaginal squamous cell carcinoma</strong> is only moderately radiosensitive, and advanced stages often require <strong>exenteration</strong>.</li>\r\n<li>Treatment for <strong>fallopian tube carcinoma</strong> primarily involves surgery followed by <strong>external pelvic radiation</strong>, not typically brachytherapy.</li>\r\n</ul>",
      "correct_choice_id": 311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Watery discharge P/V</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhage</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Sepsis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Characteristic feature of carcinoma fallopian tube:</span></p>",
      "unique_key": "DT1191038",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Watery discharge P/V (Option A)</strong> is a characteristic and often prominent symptom of fallopian tube carcinoma, specifically referred to as <strong>Hydrops tubae profluens</strong>. This is due to the accumulation and intermittent expulsion of serous fluid from the fallopian tube.</li>\r\n<li>Fallopian tube carcinoma is a <strong>rare malignancy</strong>, accounting for only 0.3% of all female genital tract cancers.</li>\r\n<li>The <strong>most common site is the ampulla of the tube</strong>, and the <strong>most common histological type is adenocarcinoma</strong>.</li>\r\n<li>It is frequently involved <strong>secondary to other cancers</strong> (e.g., ovary, endometrium, GI tract, breast, peritoneum).</li>\r\n<li>Women with <strong>BRCA1 and BRCA2 mutations</strong> have a higher risk, often leading to prophylactic salpingo-oophorectomy.</li>\r\n<li>While other symptoms like hemorrhage and pain can occur, the <strong>watery vaginal discharge is particularly characteristic</strong>. Later, this discharge may become blood-stained.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Hemorrhage (Option B):</strong> While hemorrhage (blood-stained discharge or bleeding) can occur later due to ulceration, the initial and prominent characteristic symptom is often watery discharge.</p>\r\n<p><strong>Pain (Option C):</strong> Pain can be a symptom, but it is <strong>not considered the most characteristic feature</strong> compared to the watery discharge.</p>\r\n<p><strong>Sepsis (Option D):</strong> Sepsis, or severe infection, is <strong>not a characteristic initial feature</strong> of fallopian tube carcinoma. It would be an unusual complication rather than a typical presenting symptom.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The hallmark symptom of fallopian tube carcinoma is <strong>Hydrops tubae profluens</strong>, a <strong>prominent watery vaginal discharge</strong>.</li>\r\n<li>Clinicians should consider occult tubal cancer in perimenopausal and postmenopausal women with unusual, unexplained, or persistent vaginal discharge, even without bleeding.</li>\r\n<li><strong>BRCA1 and BRCA2 mutations</strong> increase the risk.</li>\r\n</ul>",
      "correct_choice_id": 321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">CA-125: Ovarian cancer </span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">Office endometrial aspirate: Endometrial carcinoma</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear: Cervical cancer</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">Mammography: Breast cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are used for screening cancers in females except:</span></p>",
      "unique_key": "DT1191048",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Office endometrial aspirate: Endometrial carcinoma </strong>is the correct answer because an office endometrial aspirate is <strong>not routinely used for screening</strong> endometrial carcinoma.</li>\r\n<li>While transvaginal ultrasound and endometrial sampling have been suggested, their benefit for routine screening has not been established. It is primarily a <strong>diagnostic procedure</strong> performed when there is suspicion of endometrial pathology, such as abnormal uterine bleeding.</li>\r\n<li>Screening tests are used to search for an unrecognized disease or defect in apparently healthy individuals through rapidly applied tests or examinations.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509029f5214c4-5c4c-4754-a7c1-ea5e48e3b8a1.png\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509029f2b1be4-4700-4dea-9feb-6472d608b3be.png\"><p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Routine <strong>screening for endometrial cancer using methods like office endometrial aspirate or TVS is not universally recommended</strong> due to unproven benefit.</li>\r\n<li><strong>CA-125, Pap smear, and Mammography</strong> are established <strong>screening tests</strong> for ovarian cancer, cervical cancer, and breast cancer, respectively.</li>\r\n</ul>",
      "correct_choice_id": 332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">Common to those whose mothers were given diethylstilbestrol during early pregnancy</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal adenosis may progress to this conditions</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">The middle one-third is the commonest site</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">May be multicentric and may involve even the cervix as well</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following statements are related to clear cell carcinoma of the vagina except:</span></p>",
      "unique_key": "DT1191051",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>The middle one-third is the commonest site (Option C)</strong> is <strong>incorrect</strong>. Clear cell adenocarcinoma of the vagina typically involves the <strong>upper-third of the anterior vaginal wall</strong>. Therefore, stating the middle one-third as the commonest site is an exception among the given statements.</li>\r\n<li>Primary vaginal adenocarcinoma, including the clear cell type, is <strong>rare</strong>.</li>\r\n<li>It is notably found in <strong>adolescent girls</strong> with a history of <strong>intrauterine exposure to diethylstilbestrol (DES)</strong> during the first trimester of pregnancy.</li>\r\n<li>The risk of developing clear cell adenocarcinoma after DES exposure is approximately <strong>1 in 1000 or less</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Common to those whose mothers were given diethylstilbestrol during early pregnancy (Option A):</strong> This is a true statement. Clear cell adenocarcinoma of the vagina is strongly associated with <strong>intrauterine exposure to diethylstilbestrol (DES)</strong>, particularly when the mother was given it during the first trimester.</p>\r\n<p><strong>Vaginal adenosis may progress to this condition (Option B):</strong> This is a true statement. Patients with DES exposure are more likely to develop <strong>vaginal adenosis</strong>, and while rare, this condition can progress to clear cell adenocarcinoma.</p>\r\n<p><strong>May be multicentric and may involve even the cervix as well (Option D):</strong> This is a true statement. Clear cell adenocarcinoma can be <strong>multicentric</strong>, meaning it can appear in multiple locations, and it <strong>may involve the cervix</strong> in addition to the vagina.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Clear cell adenocarcinoma of the vagina is strongly linked to <strong>in utero DES exposure</strong>.</li>\r\n<li>The <strong>upper-third of the anterior vaginal wall</strong> is the commonest site, not the middle one-third.</li>\r\n<li><strong>Vaginal adenosis</strong> is a predisposing condition.</li>\r\n<li>The tumor can be <strong>multicentric</strong> and involve the <strong>cervix</strong>.</li>\r\n</ul>",
      "correct_choice_id": 343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}